Equities

Granules India Ltd

GRANULES:NSI

Granules India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)540.45
  • Today's Change-3.80 / -0.70%
  • Shares traded1.11m
  • 1 Year change+62.69%
  • Beta0.5633
Data delayed at least 15 minutes, as of Sep 20 2024 08:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments3,8112,9163,962
Total Receivables, Net11,32310,53310,452
Total Inventory13,55011,71410,104
Prepaid expenses311361204
Other current assets, total55218328
Total current assets29,05025,74125,050
Property, plant & equipment, net21,15618,59415,956
Goodwill, net------
Intangibles, net2,5172,9093,018
Long term investments215212197
Note receivable - long term1,7331,426767
Other long term assets167148127
Total assets55,21049,04645,129
LIABILITIES
Accounts payable7,4957,8216,386
Accrued expenses706512404
Notes payable/short-term debt10,5428,1097,656
Current portion long-term debt/capital leases1,0871,061988
Other current liabilities, total993632983
Total current liabilities20,82318,13516,416
Total long term debt1,5222,1922,420
Total debt13,15111,36211,063
Deferred income tax23177139
Minority interest--05.58
Other liabilities, total379293283
Total liabilities22,95420,69719,264
SHAREHOLDERS EQUITY
Common stock242242248
Additional paid-in capital1,5191,4884,560
Retained earnings (accumulated deficit)29,23925,57220,592
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1,072867298
Total equity32,25528,34925,865
Total liabilities & shareholders' equity55,21049,04645,129
Total common shares outstanding242242248
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.